Amit Sachdev Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amit Sachdev.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amit Sachdev. Amit Sachdev is EVP, Chief Patient Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CRO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, Policy, Access & Value in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Corp Affairs & Pub Policy in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Public Policy,Gov Affairs in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR).
Latest Insider Trading Transactions of Amit Sachdev
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 110.00 | 29,032 | 3,193,520 | 99,335 | 128.4 K to 99.3 K (-22.62 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 106.30 | 51,468 | 5,471,048 | 128,367 | 179.8 K to 128.4 K (-28.62 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 45.11 | 28,593 | 1,289,830 | 179,835 | 151.2 K to 179.8 K (+18.91 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 48.74 | 29,032 | 1,415,020 | 151,242 | 122.2 K to 151.2 K (+23.76 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 37.86 | 17,156 | 649,526 | 122,210 | 105.1 K to 122.2 K (+16.33 %) |
Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 38.80 | 5,719 | 221,897 | 105,054 | 99.3 K to 105.1 K (+5.76 %) |
Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 87.68 | 7,684 | 673,733 | 99,335 | 107 K to 99.3 K (-7.18 %) |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | A | 86.52 | 31,065 | 2,687,744 | 31,065 | |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Grant | A | 0.00 | 15,170 | 0 | 107,019 | 91.8 K to 107 K (+16.52 %) |
Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Grant | A | 0.01 | 5,753 | 58 | 91,849 | 86.1 K to 91.8 K (+6.68 %) |
Nov 17 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 93.36 | 116 | 10,830 | 86,096 | 86.2 K to 86.1 K (-0.13 %) |
May 18 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 81.67 | 117 | 9,555 | 86,096 | 86.2 K to 86.1 K (-0.14 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | A | 91.05 | 34,482 | 3,139,586 | 34,482 | |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 92.79 | 1,266 | 117,472 | 86,096 | 87.4 K to 86.1 K (-1.45 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 91.82 | 900 | 82,638 | 87,362 | 88.3 K to 87.4 K (-1.02 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 91.01 | 3,700 | 336,737 | 88,262 | 92 K to 88.3 K (-4.02 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 89.91 | 4,300 | 386,613 | 91,962 | 96.3 K to 92 K (-4.47 %) |
Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Grant | A | 0.01 | 17,299 | 173 | 96,262 | 79 K to 96.3 K (+21.91 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 122.28 | 85 | 10,394 | 78,963 | 79 K to 79 K (-0.11 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 126.61 | 1,100 | 139,271 | 78,963 | 80.1 K to 79 K (-1.37 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 126.01 | 2,638 | 332,414 | 80,063 | 82.7 K to 80.1 K (-3.19 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 124.94 | 1,500 | 187,410 | 82,701 | 84.2 K to 82.7 K (-1.78 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 123.34 | 700 | 86,338 | 84,201 | 84.9 K to 84.2 K (-0.82 %) |
Jul 23 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | A | 131.89 | 34,000 | 4,484,260 | 34,000 | |
May 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 123.85 | 131 | 16,224 | 84,901 | 85 K to 84.9 K (-0.15 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | M | 45.11 | 10,532 | 475,099 | 28,593 | |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | M | 48.74 | 1,468 | 71,550 | 29,032 | |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 127.90 | 200 | 25,580 | 84,901 | 85.1 K to 84.9 K (-0.24 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 127.16 | 600 | 76,296 | 85,101 | 85.7 K to 85.1 K (-0.70 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 125.93 | 2,200 | 277,046 | 85,701 | 87.9 K to 85.7 K (-2.50 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 125.07 | 1,783 | 223,000 | 87,901 | 89.7 K to 87.9 K (-1.99 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 122.78 | 300 | 36,834 | 89,684 | 90 K to 89.7 K (-0.33 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 135.08 | 12,000 | 1,620,960 | 89,984 | 102 K to 90 K (-11.77 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Buy | M | 45.11 | 10,532 | 475,099 | 101,984 | 91.5 K to 102 K (+11.52 %) |
Mar 24 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Buy | M | 48.74 | 1,468 | 71,550 | 91,452 | 90 K to 91.5 K (+1.63 %) |
Mar 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | M | 45.11 | 6,625 | 298,854 | 39,125 | |
Mar 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | M | 39.05 | 5,375 | 209,894 | 0 | |
Mar 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 130.00 | 12,000 | 1,560,000 | 89,984 | 102 K to 90 K (-11.77 %) |
Mar 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Buy | M | 45.11 | 6,625 | 298,854 | 101,984 | 95.4 K to 102 K (+6.95 %) |
Mar 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Buy | M | 39.05 | 5,375 | 209,894 | 95,359 | 90 K to 95.4 K (+5.97 %) |
Mar 01 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | M | 18.93 | 11,915 | 225,551 | 28,593 | |
Mar 01 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 45.00 | 3,972 | 178,740 | 40,154 | 44.1 K to 40.2 K (-9.00 %) |
Mar 01 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 46.00 | 11,915 | 548,090 | 44,126 | 56 K to 44.1 K (-21.26 %) |
Mar 01 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Buy | M | 18.93 | 11,915 | 225,551 | 56,041 | 44.1 K to 56 K (+27.00 %) |
Feb 24 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | M | 18.93 | 23,828 | 451,064 | 21,446 | |
Feb 24 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 44.00 | 11,914 | 524,216 | 44,126 | 56 K to 44.1 K (-21.26 %) |
Feb 24 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 43.60 | 11,914 | 519,450 | 56,040 | 68 K to 56 K (-17.53 %) |
Feb 24 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Buy | M | 18.93 | 23,828 | 451,064 | 67,954 | 44.1 K to 68 K (+54.00 %) |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | A | 38.80 | 45,750 | 1,775,100 | 45,750 | |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Grant | A | 0.01 | 10,166 | 102 | 44,126 | 34 K to 44.1 K (+29.94 %) |
Jan 25 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 39.92 | 2,128 | 84,950 | 33,960 | 36.1 K to 34 K (-5.90 %) |
Jan 20 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | M | 18.93 | 11,914 | 225,532 | 64,336 | |
Jan 20 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 39.50 | 3,750 | 148,125 | 36,088 | 39.8 K to 36.1 K (-9.41 %) |
Jan 20 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 40.00 | 11,914 | 476,560 | 39,838 | 51.8 K to 39.8 K (-23.02 %) |
Jan 20 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Buy | M | 18.93 | 11,914 | 225,532 | 51,752 | 39.8 K to 51.8 K (+29.91 %) |
Jan 13 2011 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 37.66 | 451 | 16,985 | 39,838 | 40.3 K to 39.8 K (-1.12 %) |
Oct 29 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 38.50 | 4,750 | 182,875 | 40,160 | 44.9 K to 40.2 K (-10.58 %) |
Oct 28 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Sell | S | 37.50 | 4,534 | 170,025 | 44,910 | 49.4 K to 44.9 K (-9.17 %) |
Oct 20 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Sell | S | 36.50 | 1,000 | 36,500 | 49,444 | 50.4 K to 49.4 K (-1.98 %) |
Oct 18 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Sell | S | 35.00 | 1,000 | 35,000 | 50,444 | 51.4 K to 50.4 K (-1.94 %) |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | A | 33.82 | 30,500 | 1,031,510 | 30,500 | |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | A | 39.05 | 76,250 | 2,977,563 | 76,250 | |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Grant | A | 0.01 | 10,166 | 102 | 50,983 | 40.8 K to 51 K (+24.91 %) |
Oct 26 2009 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | A | 33.00 | 60,000 | 1,980,000 | 60,000 | |
Jul 20 2009 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Option Exercise | A | 33.28 | 30,500 | 1,015,040 | 30,500 | |
May 19 2009 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Corp Affairs & ... | Sell | S | 28.44 | 783 | 22,269 | 40,366 | 41.1 K to 40.4 K (-1.90 %) |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Option Exercise | A | 33.55 | 61,000 | 2,046,550 | 61,000 | |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Grant | A | 0.01 | 12,200 | 122 | 40,366 | 28.2 K to 40.4 K (+43.31 %) |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Sell | S | 26.20 | 791 | 20,724 | 28,166 | 29 K to 28.2 K (-2.73 %) |
Jul 25 2008 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Option Exercise | A | 32.16 | 30,500 | 980,880 | 30,500 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Option Exercise | A | 18.93 | 76,250 | 1,443,413 | 76,250 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Grant | A | 0.01 | 10,166 | 102 | 28,166 | 18 K to 28.2 K (+56.48 %) |
Nov 07 2007 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Buy | P | 24.72 | 1,000 | 24,720 | 18,000 | 17 K to 18 K (+5.88 %) |
Jul 24 2007 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Option Exercise | A | 29.25 | 75,000 | 2,193,750 | 75,000 | |
Jul 24 2007 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Grant | A | 0.01 | 2,000 | 20 | 17,000 | 15 K to 17 K (+13.33 %) |
Jul 24 2007 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | SVP, Public Policy, ... | Grant | A | 0.01 | 15,000 | 150 | 15,000 | 0 to 15 K |